Key result
Antisense hybrid depletion of CaT1 decreased store-operated Ca2+ current in LNCaP prostate cancer cells by ~50%, while Casodex-induced CaT1 enhancement potentiated it by 30%.
Why the study?
Does manipulation of CaT1 levels alter store-operated Ca2+ current in LNCaP human prostate cancer epithelial cells?
Does manipulation of CaT1 levels alter store-operated Ca2+ current in LNCaP human prostate cancer epithelial cells?
CaT1 is involved in generating store-operated Ca2+ current in prostate cancer epithelial cells, likely as part of a heteromultimeric channel.
Answers are grounded in this paper and cite their sources.
May inform CaT1-targeted therapies in prostate cancer; leaves open in vivo validation and clinical translation.
Ca(2+) influx via store-operated channels (SOCs) following stimulation of the plasma membrane receptors is the key event controlling numerous processes in nonexcitable cells. The human transient receptor potential vanilloid type 6 channel, originally termed Ca(2+) transporter type 1 (CaT1) protein, is one of the promising candidates for the role of endogenous SOC, although investigations of its functions have generated considerable controversy. In order to assess the role of CaT1 in generating endogenous store-operated Ca(2+) current (I(SOC)) in the lymph node carcinoma of the prostate (LNCaP) human prostate cancer epithelial cell line, we manipulated its endogenous levels by means of antisense hybrid depletion or pharmacological up-regulation (antiandrogen treatment) combined with functional evaluation of I(SOC). Antisense hybrid depletion of CaT1 decreased I(SOC) in LNCaP cells by approximately 50%, whereas enhancement of CaT1 levels by 60% in response to Casodex treatment potentiated I(SOC) by 30%. The functional characteristics of I(SOC) in LNCaP cells were similar in many respects to those reported for heterologously expressed CaT1, although 2-aminoethoxydiphenyl borate sensitivity and lack of constitutive current highlighted notable departures. Our results suggest that CaT1 is definitely involved in I(SOC), but it may constitute only a part of the endogenous SOC, which in general may be a heteromultimeric channel composed of homologous CaT1 and other transient receptor potential subunits.
No takes yet. Share an insight, caveat, or question.
Abeele et al. (2003) studied Prostate cancer. Antisense hybrid depletion or Casodex treatment was evaluated on Store-operated Ca(2+) current (I(SOC)). Antisense hybrid depletion of CaT1 decreased store-operated Ca2+ current in LNCaP prostate cancer cells by ~50%, while Casodex-induced CaT1 enhancement potentiated it by 30%.
Synapse has enriched 10 related papers. Consider them for comparative context: